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Abstract 
Objective: To determine the effect of individualized blood pressure management targeted upon the physiology 
of individual patient could help in decreasing the risk postoperative organ dysfunction.  Methodology It was a 
randomized trial carried out in department of general medicine from March 2016 to March 2017. An approval 
from Ethics committee was taken. An informed consent in the form of a written document was taken from every 
patient. Data was analyzed by using SPSS version 24. Student t-test and χ2 test that was unadjusted was 
performed for the analysis of primary outcome. P value ≤ 0.05 was considered as significant. Results: in the 
Individualized group, Primary composite outcome was noted as (36.7%) n=55. Acute kidney injury according to 
RIFLE criteria; Risk, injury and failure was observed as (17.3%) n=26, (9.3%) n=14 and (6%) n=9 respectively. 
Use of renal replacement therapy was noted as (8%) n=12. Acute heart failure occurred in (6%) n=9. 
respectively. For Standard treatment group, Primary composite outcome was noted as (48.7%) n=73. Use of 
renal replacement therapy was noted as (6.7%) n=10. Acute heart failure occurred in (1.3%) n=2. Need for 
noninvasive or invasive ventilation and sepsis was noted as (30.7%) n=46 and (18%) n=27 respectively. 
Conclusion: High Postoperative risk patients having major abdominal surgery, the mode of management 
directed towards the individual blood pressure as compared to standard mode of management proves to be 
fruitful in decreasing the risk for postoperative organ dysfunction.  
Keywords: Blood Pressure, Organ Dysfunction, Postoperative complications, Sepsis. 
 
Introduction 
There is increasing rate of patients going through major surgery with increasing rate of improvement in the field 
of medicine1. Nonetheless, there is still a risk of morbidity and mortality among these patients due to 
complications that may arise during the surgery. one such complication is the hemodynamic imbalance2. It has 
been observed that hypotension during the surgery is related to insult to multiple critical organs such as brain, 
heart, and kidney and is associated with increased mortality among high-risk patients. Although, this 
hypotension is one of the avoidable element since arterial blood pressure can be altered with the use of IV fluids 
and vasopressin agents3. So far, no unanimity has been found on the debate of optimum blood pressure as a 
standard threshold for the optimal perfusion of these organs. At present, a decrease of "30-50% off of baseline, 
mean arterial pressure lower than 60mmHg, and systolic blood pressure of less than 80mmHg" is the standard 
threshold for the treatment in clinical practice depicting the defect in consensus4,5. Recent guides given by the 
American Heart Association and the American College of Cardiology encourage an individualized care for 
patients undergoing high-risk surgeries with comorbidities. Those patients already suffering from hypertension, 
having ill self-regulatory and feedback phenomenon of kidney and lungs are more prone to ischemia at lower 
levels of blood pressure6,7. Thence, high blood pressure targetted therapy to such patients may save the patients 
from grave risk. for critically ill patients, the consensus guide suggests adjusting blood pressure at premorbid 
levels. Nonetheless, there is lack of evidence for an individual strategy in the surgery7,8. This study has been 
carried out to establish if an individualized targetted therapy of systolic blood pressure accustomed to the 
patient's usual levels will be helpful in decreasing the likelihood of organ dysfunction in comparison to the 
customary practice9,10. 
 
Methodology 
Study design: It was a randomized trial carried out in department of general medicine from March 2016 to 
March 2017. An approval from Ethics committee was taken. An informed consent in the form of a written 
document was taken from every patient. To review blinding and the study conduct, an autonomous committee 
was formed for the monitoring of safety.  
Study Participants: The eligibility criteria included age above 50 years, surgery under general anesthesia of two 
hours or longer, having a risk of class 3 or more of acute kidney injury before the surgery, not meeting any 
exclusion criteria. The risk index for acute kidney injury varies 1 to 4, with 4 being at highest risk of acute 
kidney injury preoperatively. The exclusion criteria comprised of chronic kidney disease, acute coronary 
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syndrome, uncontrolled hypertension, decompensated heart failure, or receiving norepinephrine, or a part of 
another study. 
Study Interventions: Patients classified in 1:1 to be given standardized or individualized therapy. Patients 
resting BP was gained from their medical records to be used as a reference level. In case of unavailability of the 
records, a nurse measured the blood pressure of the patient. For the patients in conventional treatment class IV, 
was given in 6mg bolus, as determined if there was a fall in systolic blood pressure from patient’s standard 
measurement below 40% then 15. For the individual treatment class, systolic blood pressure was supposed to 
stay between ±10percent of the reference range by infusing norepinephrine continuously. It was diluted by 
addition of 0.9% saline in 250ml as 2.5mg. Both of the study groups received ringer lactate solution IV at 
4ml/kg/hr to fulfill the fluid demand. To attain a maximum level of stroke volume, 6% hydroxyethyl starch in 
0.9% saline was given as additional fluids according to the protocols of the hemodynamic log scale. For the 
patients in individual treatment class, a decrease in the levels of norepinephrine was suggested for the risk of 
bradycardia. Norepinephrine was allowed to use in the standard class of treatment when the systolic BP falls 
below the determined level after infusing a max dose of ephedrine, as a rescue treatment. The duration of 
intervention was from initiation of anesthesia to 4 hr after surgery. An attending physician was present at all 
times to scrutinize all the procedures according to the clinical criteria and practices. A catheter in radial artery 
was placed for continuous monitoring of BP in order to avoid unnecessary treatments.  
Study Outcome: The primary outcome included systemic inflammatory reaction and one organ dysfunction at 
least. The organ systems were Respiratory (requiring ventilation for respiratory depression), renal (injury, risk, 
loss, failure or end-stage kidney disease) neurologic (stroke) CVS (cardiac failure). The frequency and acerbity 
of dysfunction of the organ were determined once every day at routine evaluation during follows up. The 
secondary results comprised of the discrete element of the primary outcome, post-op complications included 
sepsis, stroke, acute heart failure, and surgical complications such as infection, a leak of the anastomosis, 
reoperation. Major adverse effects were bleeding and bradycardia.   
Blinding and Randomization: Data collection, randomization, and enrollment were done with the help of web-
based system. Randomization was done by a minimization log while stratification was performed on the basis of 
need of surgery, site of surgery, site of study. Blinding was strictly done for the data collection and follow up. 
Similarly the post-op care was providing the medical team. Investigator, statisticians, safety monitoring and data 
collecting team had no information on group tasks. Verification of outcome was done as defined by the criteria 
designed by the principal investigator. The credibility limits and quality assurance among the data were checked 
automatically for validation. Data was scrutinized additionally and was verified.  
Statistical Analysis: Data was analyzed by using SPSS version 24. Mean and SD were calculated for numerical 
variables like age, height, systolic and diasystolic blood pressure. Frequency and percentages were calculated for 
qualitative data like gender, ASA status, acute kidney injury, stroke, need of ventilation, sepsis, surgical 
complications. Student t-test and χ2 test that was unadjusted was performed for the analysis of primary outcome. 
P value ≤ 0.05 was considered as significant. 
 
Results 
A total number of 300 patients were enrolled in this study, both genders. The study patients were further divided 
into two equal groups i.e. individual treatment and standard treatment respectively. The mean age, height, 
systolic blood pressure, Diastolic blood pressure, Serum creatinine at inclusion, estimated GFR Overall mean, 
Among those with estimated GFR <60 of the individualized treatment patients’ was 59.63±4.66 years, 
165.13±2.58 cm, 135.97±7.19 mm Hg, 75.50±5.46 mm Hg, 0.94±0.31 mg/dL, 88.23±2.46 mL/min/1.73 m2, 
46.10±2.45 mL/min/1.73 m2 respectively. There were (85.3%) n=128 males and (14.7%) n=22 females. ASA 
physical status classes II, III and ≥IV was noted as (46%) n=69, (50.7%) n=76 and (3.3%) n=5 respectively. 
Acute kidney injury risk index classes III, IV and V was noted as 55.3% n=83, (28%) n=42 and (16.7%) n=25 
respectively. Chronic heart failure, Ischemic heart disease, renal impairment, Diabetes mellitus and Estimated 
GFR <60 mL/min/1.73 m2, No. (%) was (22%) n=33, (8.7%) n=13, (20%) n=30, (54.7%) n=82 and (16.7%) 
n=25 respectively. While, the mean age, height, systolic blood pressure, Diastolic blood pressure, Serum 
creatinine at inclusion, estimated GFR Overall mean, Among those with estimated GFR <60 of the 
standardardized treatment patients’ was 62.51±6.36 years, 166.45±2.96 cm, 135.24±3.12 mm Hg, 77.90±1.96 
mm Hg, 0.94±0.31 mg/dL, 87.63±2.18 mL/min/1.73 m2, 50.90±5.74 mL/min/1.73 m2 respectively.  There were 
(80.7%) n=121 males and (19.3%) n=29 females. ASA physical status classes II, III and ≥IV was noted as 
(39.3%) n=59, (58%) n=87 and (2.7%) n=4 respectively. Acute kidney injury risk index classes III, IV and V 
was noted as (50%) n=75, (36.7%) n=55 and (13.3%) n=20 respectively. Chronic heart failure, Ischemic heart 
disease, Renal impairment, Diabetes mellitus and Estimated GFR <60 mL/min/1.73 m2, No. (%) was (28.7%) 
n=43, (21.3%) n=32, (10.7%) n=16, (48.7%) n=73 and (18.7%) n=28 respectively. The differences were 
statistically significant of age (p=0.000), height (p=0.000), diastolic blood pressure (p=0.000), ischemic heart 
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disease (p=0.002), renal impairment (p=0.025), estimated GFR overall mean (p=0.026) and among those with 
estimated GFR <60 mL/min/1.73 m2 (p=0.000) with regards to groups. (Table. 1). 
Primary composite outcome was noted as (36.7%) n=55. Acute kidney injury according to RIFLE criteria; 
Risk, injury and failure was observed as (17.3%) n=26, (9.3%) n=14 and (6%) n=9 respectively. Use of renal 
replacement therapy was noted as (8%) n=12. Acute heart failure occurred in (6%) n=9. Stroke occurred in 
(1.3%) n=2. Reintubation was observed as (13.3%) n=20. Need for noninvasive or invasive ventilation and 
sepsis was noted as (18%) n=27 and (9.3%) n=14 respectively. Use of renal replacement therapy was observed 
as (3.3%) n=5. Need for noninvasive or invasive ventilation, sepsis, acute heart failure, stroke, surgical site 
infection, surgical reoperation, anastomotic leakage was observed as (20.7%) n=31, (16%) n=24, (2.7%) n=4, 
(2%) n=3, (15.3%) n=23, (16.7%) n=25 and (19.3%) n=29 respectively. While, death at day 30 was occurred 
(6%) n=9 patients. 
Primary composite outcome was noted as (48.7%) n=73. Acute kidney injury according to RIFLE criteria; 
Risk, injury and failure was observed as (27.3%) n=41, (14.7%) n=22 and (9.3%) n=14 respectively. Use of 
renal replacement therapy was noted as (6.7%) n=10. Acute heart failure occurred in (1.3%) n=2. Stroke 
occurred in (0.7%) n=1. Reintubation was observed as (12%) n=18. Need for noninvasive or invasive ventilation 
and sepsis was noted as (30.7%) n=46 and (18%) n=27 respectively. Use of renal replacement therapy was 
observed as (8%) n=12. Need for noninvasive or invasive ventilation, sepsis, acute heart failure, stroke, surgical 
site infection, surgical reoperation, anastomotic leakage was observed as (26%) n=39, (28%) n=42, (10.7%) 
n=16, (0.7%) n=1, (30.7%) n=46, (27.3%) n=41 and (15.3%) n=23 respectively. While, death at day 30 was 
occurred (6.7%) n=10 patients. 
The differences were statistically significant of Primary composite outcome (p=0.036), risk (p=0.038), 
Need for noninvasive or invasive ventilation (p=0.011), sepsis (p=0.029). Whereas; the differences were also 
significant of sepsis (p=0.012), acute heart failure (p=0.005), Surgical site infection (p=0.002), Surgical 
reoperation (p=0.026). (Table. 2). 
Table. 1 
Baseline characteristics among both the groups  
Characteristics Individual 
treatment 
(n=150) 
Standard 
treatment 
(n=150) 
P 
Value 
Age 59.63±4.66 62.51±6.36 0.000 
Gender 
Male (85.3%) n=128 (80.7%) n=121 0.282 
Female (14.7%) n=22 (19.3%) n=29 
Height cm 165.13±2.58 166.45±2.96 0.000 
ASA physical status class 
II (46%) n=69 (39.3%) n=59 0.442 
III (50.7%) n=76 (58%) n=87 
≥IV (3.3%) n=5 (2.7%) n=4 
Acute kidney injury risk index class 
III 55.3% n=83 (50%) n=75 0.259 
IV (28%) n=42 (36.7%) n=55 
V (16.7%) n=25 (13.3%) n=20 
Reference blood pressure, mm Hg 
Systolic 135.97±7.19 135.24±3.12 0.258 
Diastolic 75.50±5.46 77.90±1.96 0.000 
Preexisting conditions 
Chronic heart failure (22%) n=33 (28.7%) n=43 0.184 
Ischemic heart disease (8.7%) n=13 (21.3%) n=32 0.002 
Renal impairment (20%) n=30 (10.7%) n=16 0.025 
Diabetes mellitus (54.7%) n=82 (48.7%) n=73 0.298 
Serum creatinine at inclusion, mean (SD), mg/dL 0.94±0.31 0.94±0.31 1.0 
Estimated GFR 
Overall, mean, mL/min/1.73 m2 88.23±2.46 87.63±2.18 0.026 
Among those with estimated GFR <60 mL/min/1.73 
m2, mL/min/1.73 m2 
46.10±2.45 50.90±5.74 t0.000 
Estimated GFR <60 mL/min/1.73 m2 (16.7%) n=25 (18.7%) n=28 0.650 
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Table. 2 
Distribution of Primary and Secondary Outcomes among the Groups 
Characteristics Individual treatment 
(n=150) 
Standard treatment 
(n=150) 
P Value 
Primary Outcome 
Primary composite outcome (36.7%) n=55 (48.7%) n=73 0.036 
Secondary Outcome 
Complications within 7 days 
Acute kidney injury according to RIFLE criteria 
Risk (17.3%) n=26 (27.3%) n=41 0.038 
Injury (9.3%) n=14 (14.7%) n=22 0.155 
Failure (6%) n=9 (9.3%) n=14 0.278 
Use of renal replacement therapy (8%) n=12 (6.7%) n=10 0.658 
Acute heart failure (6%) n=9 (1.3%) n=2 0.032 
Stroke (1.3%) n=2 (0.7%) n=1 0.562 
Reintubation (13.3%) n=20 (12%) n=18 0.728 
Need for noninvasive or invasive ventilation (18%) n=27 (30.7%) n=46 0.011 
Sepsis (9.3%) n=14 (18%) n=27 0.029 
Complications within 30 days 
Use of renal replacement therapy (3.3%) n=5 (8%) n=12 0.080 
Need for noninvasive or invasive ventilation (20.7%) n=31 (26%) n=39  0.275 
Sepsis (16%) n=24 (28%) n=42 0.012 
Acute heart failure (2.7%) n=4 (10.7%) n=16 0.005 
Stroke (2%) n=3 (0.7%) n=1 0.314 
Surgical complications  
Surgical site infection (15.3%) n=23 (30.7%) n=46 0.002 
Surgical reoperation (16.7%) n=25 (27.3%) n=41 0.026 
Anastomotic leakage (19.3%) n=29 (15.3%) n=23 0.360 
Death at day 30 (6%) n=9 (6.7%) n=10 0.813 
 
Discussion 
For every surgery and every procedure, there are certain complications and the risks that come along with them. 
But for every complication is a cure. As said by Pelosi P et al 11, "Good things come in threes: prevention, early 
recognition, and treatment " this is true for all the complicated cases and the risks associated with surgery 
endangering organ and system dysfunction. If these three simple steps are properly looked upon, patients can be 
saved from grave difficulties. These steps include identifying high-risk patients; prevent adverse effects from 
occurring and early apprehension and immediate treatment of the complexities that arise as a result of surgery 
either within the duration of surgery or after that. It can rescue the crisis of organ dysfunction or failure as a 
complication and hence mortality and morbidity rates can be declined. For this purpose, an individual strategy 
must be applied to all these components keeping in view the physiologic processes.  
An appropriate knowledge of circulatory physiology plays a vital role in the prevention of complications, 
says Green 12. A drawback of improper understanding has led to the development of interventions such as flow 
monitoring. It has been observed that they lead to fluid and sodium overload. This is of significant importance 
for patients having high risk. the increasing number of these patients has made it necessary for re-evaluating the 
eduction upon circulatory physiology and its management. It is advised to use multimodal therapy for achieving 
the maximum benefits and decreasing morbidity and complications. 
Maintenance of vitals during a surgery is a crucial task. Such as control of hemodynamics. Labufeb L et al 
13 claims that it initiates with the identification of patients having high risks. This delamination is required to 
determine the treatment of choice for control of hemodynamics bringing together the use of minimally invasive 
methods. the main target of hemodynamic approach is to attain a harmony between supply and demand of 
oxygen. Stroke volume is greatly affected by volume replacement on the basis of fluid titration. If the 
microcirculatory system is working optimally it’s the best assurance of achieving the target. Similarly, Vincent J 
et al 14 found out that monitoring of CVS is crucial in maintaining the period hemodynamics. It has been 
observed that more than the use of devices, the correct interpretation of cardiac variables hs proved to be fruitful 
in saving the life of patients and preventing complications. For this purpose individual systems in the body must 
be paid appropriate attention according to the need and status of patients before starting the surgery keeping in 
view the complications and risk factors. Multiple variables must be integrated to achieve this goal. The physician 
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must be aware of interpretations and outcomes of all the" tools and parameters used in perioperative care". 
For the above-mentioned purpose, the concept of goal-directed therapy is worth considering. There are 
multiple advantages of GDT over conventional fluid therapy in patients of cardiac surgery as seen by Li P et al 15 
it brings about a significant reduction in the duration of hospital stay, morbidity, and mortality. The shorter 
duration of hospital shows that optimal ranges of hemodynamics improve the post-op recovery. Similar results 
have been demonstrated in a study by R. Makaryus et al 16 a decrease in LOS as well as multiple complications 
is seen after the application of goal-directed therapy. It has also been observed that early oral hydration after the 
surgery causes rapid remedial and rehabilitation after surgery. It is advised to keep the levels of IV Fluids to the 
least level and it should be independent of urinary output. Elaboration of "perioperative fluid management" must 
be done to recuperate tissue oxygenation, wound healing, pulmonary function, and GIT motility. Analogous 
results have been achieved in the study by Osawa EA et al 17. They observed the GDT including the use if blood 
transfusions, fluids, and inotropes after a cardiac surgery in high-risk patients decreased the likelihood of 30-day 
morbidity and main complications. GDT reduces the rate of complication by 11%. As well as, decreases the 
length of hospital stay and postoperative mortality. 
The GDT for fluids improves the results by an individual approach such as oxygen level management with 
the help of IV fluid administration and vasoactive infusions Manning M et al 18. GDP has shown improvements 
over the conventional excessive administration of fluid. But it didn't demonstrate any aberrations when a 
comparison was made with restrictive therapy and extreme protocols for recovery. Although postop hypotension 
management is disputatious, it includes a mi of vasopressors, IV fluid, and other agents and methods. Excessive 
salt administration is advised to be restrained from. 
A study conducted by Aronson S et al 19 has shown that perioperative blood pressure is directly related to 
the outcomes whereas it is hard to establish if untreated intraop hypotension or treated hypotension (with IV 
fluids or vasopressors) affects the outcomes as such. Although it is seen that every patient has his own 
"personalized signature of an acceptable low intraoperative BP" on the basis of his baseline blood pressure. In 
accordance with this statement, Futier E et al 20 found out that patients having abdominal surgery with high 
postoperative risk, postoperative organ dysfunction can be prevented by focusing on the management of 
individual therapy against SBP rather than accustomed standard therapy. 
 
Conclusion 
High Postoperative risk patients having major abdominal surgery, the mode of managment directed towards the 
individual blood pressure as compared to standard mode of managment proves to be fruitful in decreasing the 
risk for postoperative organ dysfunction. 
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